MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.
MarvelBiome has raised $39.6M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
MarvelBiome's investors include DRADS Capital.
MarvelBiome is headquartered in Woburn, United States.
MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.
MarvelBiome is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MarvelBiome — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/marvelbiome. Accessed September 14, 2026.
VCBacked. (2025). MarvelBiome — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/marvelbiome
{{cite web |title=MarvelBiome — Funding & Investors |url=https://www.vcbacked.co/company/marvelbiome |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated